EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 370 filers reported holding EXELIXIS INC in Q3 2020. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,250 | +15.7% | 11,052 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $208,450 | -12.1% | 10,931 | -10.5% | 0.00% | 0.0% |
| Q1 2023 | $237,223 | -71.6% | 12,220 | -64.0% | 0.00% | -50.0% |
| Q4 2022 | $834,778 | +415.3% | 33,955 | +226.1% | 0.00% | +100.0% |
| Q3 2022 | $162,000 | -22.1% | 10,412 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $208,000 | -8.8% | 10,506 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $228,000 | +8.6% | 9,992 | +7.9% | 0.00% | 0.0% |
| Q1 2021 | $210,000 | -12.1% | 9,264 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $239,000 | -7.7% | 9,760 | -10.6% | 0.00% | 0.0% |
| Q2 2020 | $259,000 | +19.9% | 10,918 | -10.7% | 0.00% | 0.0% |
| Q3 2019 | $216,000 | -50.7% | 12,230 | -40.4% | 0.00% | -50.0% |
| Q2 2019 | $438,000 | -51.5% | 20,513 | -46.0% | 0.00% | -60.0% |
| Q1 2019 | $903,000 | +0.4% | 37,958 | -16.9% | 0.01% | 0.0% |
| Q4 2018 | $899,000 | +54.5% | 45,699 | +39.2% | 0.01% | +66.7% |
| Q3 2018 | $582,000 | -28.5% | 32,836 | -13.2% | 0.00% | -25.0% |
| Q2 2018 | $814,000 | -19.5% | 37,849 | -17.1% | 0.00% | -20.0% |
| Q1 2018 | $1,011,000 | -38.1% | 45,641 | -15.1% | 0.01% | -44.4% |
| Q4 2017 | $1,633,000 | +21.8% | 53,762 | -2.8% | 0.01% | +28.6% |
| Q3 2017 | $1,341,000 | +2.8% | 55,324 | +4.4% | 0.01% | -12.5% |
| Q2 2017 | $1,305,000 | +9.5% | 53,004 | -3.7% | 0.01% | +14.3% |
| Q1 2017 | $1,192,000 | +45.4% | 55,015 | 0.0% | 0.01% | +40.0% |
| Q4 2016 | $820,000 | +16.6% | 55,015 | 0.0% | 0.01% | +25.0% |
| Q3 2016 | $703,000 | +79.8% | 55,015 | +10.0% | 0.00% | +33.3% |
| Q2 2016 | $391,000 | +530.6% | 50,000 | +205.6% | 0.00% | – |
| Q2 2015 | $62,000 | +93.8% | 16,362 | +30.2% | 0.00% | – |
| Q1 2015 | $32,000 | +77.8% | 12,562 | 0.0% | 0.00% | – |
| Q4 2014 | $18,000 | -10.0% | 12,562 | -3.3% | 0.00% | – |
| Q3 2014 | $20,000 | – | 12,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |